These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 31128064)
1. Prognostic Relevance of SFRP1 Gene Promoter Methylation in Colorectal Carcinoma. Kumar A; Gosipatala SB; Pandey A; Singh P Asian Pac J Cancer Prev; 2019 May; 20(5):1571-1577. PubMed ID: 31128064 [TBL] [Abstract][Full Text] [Related]
2. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma. Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013 [TBL] [Abstract][Full Text] [Related]
3. Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients. Rawson JB; Manno M; Mrkonjic M; Daftary D; Dicks E; Buchanan DD; Younghusband HB; Parfrey PS; Young JP; Pollett A; Green RC; Gallinger S; McLaughlin JR; Knight JA; Bapat B Carcinogenesis; 2011 May; 32(5):741-7. PubMed ID: 21304055 [TBL] [Abstract][Full Text] [Related]
4. Hypermethylated Promoters of Secreted Frizzled-Related Protein Genes are Associated with Colorectal Cancer. Hu H; Wang T; Pan R; Yang Y; Li B; Zhou C; Zhao J; Huang Y; Duan S Pathol Oncol Res; 2019 Apr; 25(2):567-575. PubMed ID: 30368728 [TBL] [Abstract][Full Text] [Related]
5. DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients. Liu X; Fu J; Bi H; Ge A; Xia T; Liu Y; Sun H; Li D; Zhao Y BMC Cancer; 2019 Dec; 19(1):1212. PubMed ID: 31830937 [TBL] [Abstract][Full Text] [Related]
6. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer. Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433 [TBL] [Abstract][Full Text] [Related]
7. [The Evaluation Value of Methylation Status of CpG Island of SFRP1 and LINE1 Gene Promoter Area in the Prognosis of Hepatocellular Carcinoma.]. Huang Y; Wei L; Sun AM; Zhao RC; Zhang J; Yang HT; Li B; Sun CJ; Ding XQ; Gao B; Zhong YQ; Qin Y Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):883-888. PubMed ID: 28598118 [TBL] [Abstract][Full Text] [Related]
8. Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor. Qi J; Zhu YQ; Luo J; Tao WH World J Gastroenterol; 2006 Nov; 12(44):7113-7. PubMed ID: 17131472 [TBL] [Abstract][Full Text] [Related]
9. IGFBP3 gene promoter methylation analysis and its association with clinicopathological characteristics of colorectal carcinoma. Kumar A; Singh P; Pandey A; Gosipatala SB Mol Biol Rep; 2020 Sep; 47(9):6919-6927. PubMed ID: 32929656 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells. Wu Y; Li J; Sun CY; Zhou Y; Zhao YF; Zhang SJ Neoplasma; 2012; 59(3):326-32. PubMed ID: 22296502 [TBL] [Abstract][Full Text] [Related]
11. The Wnt antagonist sFRP1 in colorectal tumorigenesis. Caldwell GM; Jones C; Gensberg K; Jan S; Hardy RG; Byrd P; Chughtai S; Wallis Y; Matthews GM; Morton DG Cancer Res; 2004 Feb; 64(3):883-8. PubMed ID: 14871816 [TBL] [Abstract][Full Text] [Related]
12. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma. Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071 [TBL] [Abstract][Full Text] [Related]
13. The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis. Dees C; Schlottmann I; Funke R; Distler A; Palumbo-Zerr K; Zerr P; Lin NY; Beyer C; Distler O; Schett G; Distler JH Ann Rheum Dis; 2014 Jun; 73(6):1232-9. PubMed ID: 23698475 [TBL] [Abstract][Full Text] [Related]
14. Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance. Boughanem H; Pilo J; García-Flores LA; Arranz I; Ramos-Fernandez M; Ortega-Castan M; Crujeiras AB; Sandoval J; Macias-Gonzalez M J Transl Med; 2024 May; 22(1):509. PubMed ID: 38802858 [TBL] [Abstract][Full Text] [Related]
15. Circulating methylated RUNX3 and SFRP1 genes as a noninvasive panel for early detection of colorectal cancer. Pasha HF; Radwan MI; Yehia AM; Toam MM Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1342-1349. PubMed ID: 31524773 [TBL] [Abstract][Full Text] [Related]
16. High-risk HPV infection modulates the promoter hypermethylation of APC, SFRP1, and PTEN in cervical cancer patients of North India. Kadian LK; Yadav R; Nanda S; Gulshan G; Sharma S; Yadav C Mol Biol Rep; 2020 Dec; 47(12):9725-9732. PubMed ID: 33230782 [TBL] [Abstract][Full Text] [Related]
17. Prognostic potential of KLOTHO and SFRP1 promoter methylation in head and neck squamous cell carcinoma. Alsofyani AA; Alsiary RA; Samkari A; Alhaj-Hussain BT; Khan JA; Al-Maghrabi J; Elaimi A; Al-Qahtani MH; Abuzenadah AM; Dallol A J Appl Genet; 2017 Nov; 58(4):459-465. PubMed ID: 28812223 [TBL] [Abstract][Full Text] [Related]
18. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer. Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations. Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106 [TBL] [Abstract][Full Text] [Related]
20. Functional analyses and prognostic significance of SFRP1 expression in bladder cancer. Rogler A; Kendziorra E; Giedl J; Stoehr C; Taubert H; Goebell PJ; Wullich B; Stöckle M; Lehmann J; Petsch S; Hartmann A; Stoehr R J Cancer Res Clin Oncol; 2015 Oct; 141(10):1779-90. PubMed ID: 25732201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]